ClinVar Miner

Submissions for variant NM_001365536.1(SCN9A):c.3089T>C (p.Leu1030Pro)

gnomAD frequency: 0.00005  dbSNP: rs200958860
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000706571 SCV000835630 likely benign Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 2022-09-01 criteria provided, single submitter clinical testing
Ambry Genetics RCV002442536 SCV002752935 uncertain significance Inborn genetic diseases 2021-02-05 criteria provided, single submitter clinical testing The p.L1019P variant (also known as c.3056T>C), located in coding exon 16 of the SCN9A gene, results from a T to C substitution at nucleotide position 3056. The leucine at codon 1019 is replaced by proline, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and proline is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of primary erythermalgia/small fiber neuropathy and paroxysmal extreme pain disorder (PEPD); however, its contribution to the development of congenital insensitivity to pain (CIP) and hereditary sensory autonomic neuropathy type II (HSAN2D) is uncertain.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.